142 related articles for article (PubMed ID: 36707944)
21. Parameningeal rhabdomyosarcoma: results of an international workshop.
Benk V; Rodary C; Donaldson SS; Flamant F; Maurer H; Treuner I; Carli M; Gehan E
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):533-40. PubMed ID: 8948336
[TBL] [Abstract][Full Text] [Related]
22. Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group.
Lawrence W; Anderson JR; Gehan EA; Maurer H
Cancer; 1997 Sep; 80(6):1165-70. PubMed ID: 9305719
[TBL] [Abstract][Full Text] [Related]
23. Adherence to Treatment, Response and Patterns of Failure in Pediatric Parameningeal Rhabdomyosarcoma: Experience From a Tertiary Cancer Care Center From India.
Roy S; Pathy S; Mohanti BK; Chander S; Biswas A
J Pediatr Hematol Oncol; 2017 Mar; 39(2):e62-e68. PubMed ID: 28060113
[TBL] [Abstract][Full Text] [Related]
24. Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcoma.
Clement SC; Schoot RA; Slater O; Chisholm JC; Abela C; Balm AJM; van den Brekel MW; Breunis WB; Chang YC; Davila Fajardo R; Dunaway D; Gajdosova E; Gaze MN; Gupta S; Hartley B; Kremer LCM; van Lennep M; Levitt GA; Mandeville HC; Pieters BR; Saeed P; Smeele LE; Strackee SD; Ronckers CM; Caron HN; van Santen HM; Merks JHM
Eur J Cancer; 2016 Feb; 54():1-10. PubMed ID: 26707591
[TBL] [Abstract][Full Text] [Related]
25. [Clinical characteristics and prognosis analysis of 46 cases of newly diagnosed localized head and neck rhabdomyosarcoma].
Zhang CG; Zhou SY; Liu P; Qin Y; Yang JL; He XH; Shi YK
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(34):2722-2726. PubMed ID: 30220168
[No Abstract] [Full Text] [Related]
26. Long-term results in children with head and neck rhabdomyosarcoma: A report from the Italian Soft Tissue Sarcoma Committee.
Affinita MC; Ferrari A; Milano GM; Scarzello G; De Leonardis F; Coccoli L; Pericoli R; Basso E; Zanetti I; Scagnellato A; Bisogno G
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115716
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
[TBL] [Abstract][Full Text] [Related]
28. Extremity sarcomas: an analysis of prognostic factors from the Intergroup Rhabdomyosarcoma Study III.
Andrassy RJ; Corpron CA; Hays D; Raney RB; Wiener ES; Lawrence W; Lobe TE; Bagwell C; Maurer HM
J Pediatr Surg; 1996 Jan; 31(1):191-6. PubMed ID: 8632278
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of factors influencing treatment results in children with soft tissue head and neck sarcomas - in the material of the Department of Paediatrics, Haematology, Oncology and Endocrinology, Medical University of Gdansk].
Bień E; Stachowicz-Stencel T; Adamkiewicz-Drozyńska E; Połczyńska K; Sierota D; Stefanowicz J; Szołkiewicz A; Hennig M; Krawczyk M; Balcerska A
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1074-81. PubMed ID: 19531829
[TBL] [Abstract][Full Text] [Related]
30. Treatment outcome of rhabdomyosarcoma in Hong Kong Chinese children.
Yuan XJ; Chan GC; Chan SK; Shek TW; Kwong DL; Wei WI; Ha SY; Chiang AK
Hong Kong Med J; 2008 Apr; 14(2):116-23. PubMed ID: 18382018
[TBL] [Abstract][Full Text] [Related]
31. Ophthalmic involvement as a presenting feature of nonorbital childhood parameningeal embryonal rhabdomyosarcoma.
Mullaney PB; Nabi NU; Thorner P; Buncic R
Ophthalmology; 2001 Jan; 108(1):179-82. PubMed ID: 11150285
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in children with head and neck rhabdomyosarcoma: A 12-year retrospective study.
Zhang Y; Zhang WL; Huang DS; Wang YZ; Hu HM; Mei YY; Zhi T
Brain Behav; 2020 Aug; 10(8):e01697. PubMed ID: 32548972
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and long-term outcomes of rhabdomyosarcoma in Korean children, adolescents and young adults: a single-center experience.
Park M; Lee JA; Jin HY; Kim JY; Park JW; Kim JH; Kang HG; Park SY; Park EY; Park HJ; Park BK
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3109-3119. PubMed ID: 35870013
[TBL] [Abstract][Full Text] [Related]
34. Improved outcome for patients with middle ear rhabdomyosarcoma: a children's oncology group study.
Hawkins DS; Anderson JR; Paidas CN; Wharam MD; Qualman SJ; Pappo AS; Scott Baker K; Crist WM
J Clin Oncol; 2001 Jun; 19(12):3073-9. PubMed ID: 11408504
[TBL] [Abstract][Full Text] [Related]
35. Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
Curtis AE; Okcu MF; Chintagumpala M; Teh BS; Paulino AC
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):173-7. PubMed ID: 18501529
[TBL] [Abstract][Full Text] [Related]
36. Role of Surgery in Rhabdomyosarcoma of the Head and Neck in Children.
Dombrowski ND; Wolter NE; Robson CD; Kawai K; Irace AL; Vargas SO; Marcus KJ; Mack JW; Collins NB; Rahbar R
Laryngoscope; 2021 Mar; 131(3):E984-E992. PubMed ID: 33107076
[TBL] [Abstract][Full Text] [Related]
37. Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Heske CM; Chi YY; Venkatramani R; Li M; Arnold MA; Dasgupta R; Hiniker SM; Hawkins DS; Mascarenhas L
Cancer; 2021 Mar; 127(6):946-956. PubMed ID: 33216382
[TBL] [Abstract][Full Text] [Related]
38. Parameningeal rhabdomyosarcoma: outcomes and opportunities.
Yang JC; Wexler LH; Meyers PA; Wolden SL
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e61-6. PubMed ID: 23021437
[TBL] [Abstract][Full Text] [Related]
39. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001).
Abd El-Aal HH; Habib EE; Mishrif MM
J Egypt Natl Canc Inst; 2006 Mar; 18(1):51-60. PubMed ID: 17237856
[TBL] [Abstract][Full Text] [Related]
40. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.
Missiaglia E; Williamson D; Chisholm J; Wirapati P; Pierron G; Petel F; Concordet JP; Thway K; Oberlin O; Pritchard-Jones K; Delattre O; Delorenzi M; Shipley J
J Clin Oncol; 2012 May; 30(14):1670-7. PubMed ID: 22454413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
